Open opportunities (fellowships, awards, training, research, funding, career, etc.) of interest to NEALS members can be found here. Please contact Carly Allen, NEALS Communications and Outreach Manager, at callen@neals.org to submit an announcement for posting on the website.
Posted Date: Sep 30, 2022
Current Closing Date for Applications: Jan 05, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Estimated Total Program Funding: $7,500,000
Award Ceiling: $500,000
The Centers for Disease Control/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) is seeking investigator-initiated research that will further the understanding of potential risk factors for Amyotrophic Lateral Sclerosis (ALS), while supporting the National ALS Registry"s mission. The National ALS Registry"s goals are to estimate the number of new ALS cases each year, estimate the number of people who have ALS at a specific point in time, better understand who gets ALS, and identify what contributing factors, including environmental, may affect ALS. CDC/ATSDR is seeking investigator-initiated research that will identify and evaluate risk factors contributing to ALS, with preferred focus in this Notice of Funding Opportunity on factors related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. Research proposals on preferred topics can be funded under one of two funding options, Funding Option A or Funding Option B.Funding Option A is intended to support ALS risk factor research investigations that have an existing, well substantiated evidence base and would benefit from strengthened rigorous evaluation. Funding Option B is intended to support novel ALS risk factor research investigations that may or may not have an existing evidence base foundation base, may be supported by limited and insuffiicient preliminary research, and are exploratory and developmental in nature.
Click here for more information and to apply.Shockingly, more than 150 years after the disease was first defined, there are currently no universally accepted diagnostic approaches for ALS. In order to receive an ALS diagnosis patients must first undergo a battery of tests designed to rule out other diagnoses. This is highly problematic because it can take a year for an ALS patient to receive the correct diagnosis (and sometimes even longer).While these individuals are searching for a name for their affliction, they are frequently bounced to multiple doctors, can receive unnecessary (and expensive) surgical procedures and medications, and sadly can become ineligible for ALS clinical trials. The ALS field urgently needs to close this gap!
Given this critical need in the field, ALSFAC is pleased to issue an open call for proposals designed to encourage the identification of early diagnostic markers of ALS. We are particularly interested in encouraging diverse and multidisciplinary research teams to attack this problem.
Examples of approaches that might be supported by this request for proposals include, but are not limited to, the following:
Applications open: October 17, 2023
Applications due: January 16, 2023
Funding to start: Q2, 2023
Submit to: https://app.box.com/f/6332c1c7e65b46969236884f37cf7535
Grants are for the support of 3-year proposals of up to $500,000 USD total (inclusive of a maximum of 15% in indirect costs). Support will not normally exceed 3 years and applicants should submit proposals that are compatible with a 3-year time frame. The continuation of funding within this period will be subject to the submission of satisfactory progress reports, which will be required at six-month intervals.
Application Process
1.Please provide a cover letter addressed to ALS Finding a Cure and the Leandro P. Rizzuto Foundation including:
2.Provide a study plan including:
3.Signed and dated investigator CVs
4.Financial Disclosure Form: use either NIH form (https://ethics.od.nih.gov/forms450), or institutional form.
Please submit questions to email hidden; JavaScript is required
To learn more about ALS Finding a Cure click here
The Department of Neurology at Rutgers Robert Wood Johnson (RWJ) Medical School is seeking a full-time faculty member with interest in Neuromuscular Disorders. Candidates must be graduates of an ACGME accredited neurology residency, are board certified and have strong interests in clinical research and teaching.
The Robert Wood Johnson Medical School, Department of Neurology is part of Rutgers University in New Brunswick/Piscataway and is affiliated with the Robert Wood Johnson University Hospital, the primary teaching hospital for Rutgers RWJ Medical School. The Department of Neurology at Rutgers-RWJ Medical School is an academic department with more than 30 full time faculty and 5 nationally recognized centers of excellence.
Rutgers, The State University of New Jersey, is an Affirmative Action/Equal Opportunity Employer, M/F/D/V and a member of the State University Health System of NJ. Rutgers, The State University of New Jersey, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, gender identity or expression, disability, age, or any other category covered by law in its admission, programs, activities, or employment matters.
For further information on the notice of nondiscrimination, you may contact the U.S. Department of Education, Office for Civil Rights, at 646-428-3900 or email hidden; JavaScript is required
Women and minorities are strongly encouraged to apply.
Duties Description & Apply Online: https://jobs.rutgers.edu/postings/131671
For consideration, please send a letter of interest and CV to:
Suhayl Dhib-Jalbut, MD
Professor & Chairman of Neurology
Ruth Dunietz Kushner and Michael Jay Serwitz Chair in Multiple Sclerosis
Rutgers-New Jersey Medical School & Robert Wood Johnson Medical School
Mailing: Department of Neurology, 125 Paterson St. Ste. 6200
New Brunswick, NJ 08901 Email: email hidden; JavaScript is required
The Department of Neurology at Rutgers Robert Wood Johnson (RWJ) Medical School is seeking a full-time faculty member to serve as Division Chief of Neuromuscular Disorders. Candidates must be graduates of an ACGME accredited neurology residency, are board certified and have strong interests in clinical research and teaching. Candidate must have fellowship training in Neuromuscular Disorders and electromyography with academic and administrative experience. Academic rank will be consistent with qualifications and experience. He/she will supervise division faculty, fellows, nurse practitioners and research assistants, oversee clinical care delivered by division faculty, and promotes investigator-initiated scholarship by division members. Candidate will also oversee the MDA-designated ALS Center of Excellence. Candidate will report to the Chairman of the Department of Neurology.
The Robert Wood Johnson Medical School, Department of Neurology is part of Rutgers University in New Brunswick/Piscataway and is affiliated with the Robert Wood Johnson University Hospital, the primary teaching hospital for Rutgers RWJ Medical School. The Department of Neurology at Rutgers-RWJ Medical School is an academic department with more than 30 full time faculty and 5 nationally recognized centers of excellence.
Rutgers, The State University of New Jersey, is an Affirmative Action/Equal Opportunity Employer, M/F/D/V and a member of the State University Health System of NJ. Rutgers, The State University of New Jersey, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, gender identity or expression, disability, age, or any other category covered by law in its admission, programs, activities, or employment matters.
For further information on the notice of nondiscrimination, you may contact the U.S. Department of Education, Office for Civil Rights, at 646-428-3900 or email hidden; JavaScript is required
Women and minorities are strongly encouraged to apply.
Apply Online: https://jobs.rutgers.edu/postings/125703
For consideration, please send a letter of interest and CV to:
Suhayl Dhib-Jalbut, MD
Professor & Chairman of Neurology
Ruth Dunietz Kushner and Michael Jay Serwitz Chair in Multiple Sclerosis
Rutgers-New Jersey Medical School & Robert Wood Johnson Medical School
Mailing: Department of Neurology, 125 Paterson St. Ste. 6200
New Brunswick, NJ 08901 Email: email hidden; JavaScript is required
MDA provides support for research throughout the pipeline of drug development from discovery research through clinical trials. Funding opportunities exist for both academic investigators as well as for biotech and pharma seeking to develop therapies for neuromuscular disease.
Learn about all our grant programs and find deadlines and instructions on how to apply.